The first batch of nearly 2 million doses of COVID19 vaccine from Chinese company Sinovac arrived in Chile on Thursday. The vaccine obtained emergency use authorization in Chile on January 20.
Sinovac vaccine arrived in Chile
Chile approved CoronaVac by China’s Sinovac
Chile’s health regulator approved the emergency roll-out of the CoronaVac COVID19 vaccine produced by China’s Sinovac, with 2 million vaccines scheduled to arrive in the next week.
Ukraine to buy Sinovac vaccine
Ukraine has signed an agreement to buy 1.8 million doses of China’s Sinovac COVID19 vaccine which are expected to arrive in the country soon, the presidential office said on Wed.
Philippines vaccine procurement agreement with Sinovac Biotech
The Philippines has signed a vaccine procurement agreement with China’s Sinovac Biotech to purchase 25 million doses of the COVID-19 vaccine from Sinovac, and the first batch is expected to arrive in the Philippines in February, according to Philippine Health Secretary Francisco Duque.
Sinopharm COVID19 vaccines arrived in Jordan
1-9-21 The first batch of Sinopharm COVID19 vaccines developed by China arrived in Jordan. The local drug administration also said Sat it has approved the emergency use of the vaccine. Inoculations will begin on Wed, Jordan’s Health Ministry said.
Brazil to acquire 100 mln Sinovac’s vaccine
1-8-20 China-developed Sinovac’s vaccine reported 78% efficacy rate in Brazil’s trials. It is stepping closer to official approval in China and experts said it is a “good vaccine” in results, but further data needed.
United Arab Emirates to manufacture Sinopharm vaccines
1-6-21 The United Arab Emirates announced its plan to manufacture Sinopharm vaccines in the country under the authorization of the Chinese company. UAE will import millions more doses of vaccines from China, said a local medical department on Wed.
Who shouldn’t take the vaccine
哪些人不适合接种新冠疫苗？今天下午，在北京市新型冠状病毒肺炎疫情防控工作第200场新闻发布会上，北京市疾病预防控制中心副主任庞星火介绍，不适合接种的人群包括孕妇、哺乳期妇女，正处在发热、感染等疾病急性期、患免疫缺陷或免疫紊乱的人群以及严重的肝肾疾病、药物不可控制的高血压、糖尿病并发症、恶性肿瘤患者等人员。所有接种人员在接种前要详细阅读知情同意书，身体不适可暂缓接种。不在18岁至59岁接种年龄段范围的人员，需要等待进一步临床试验数据披露，明确是否后续能够接种。
Sinovac Biotech vaccine arrived in Indonesia
1-1-21 A total of 1.8 million doses of COVID-19 vaccine made by the Chinese biopharmaceutical company Sinovac Biotech on Thursday arrived in Indonesia, according to Indonesian government officials.
1-10-21 China plans to send 15 million doses of semi-finished COVID19 vaccine doses to Indonesia next Tuesday, the third batch of Chinese vaccines produced by Sinovac to Indonesia, after the first two batches totalling 3 million doses.
1-11-21 Indonesia gave Sinovac Biotech’s COVID-19 vaccine its first emergency use approval outside China on Monday,
China’s first new coronavirus vaccine conditionally marketed
The State Council released on the 31st, the new inactivated coronavirus vaccine of Sinopharm Group China Biological has been approved by the State Drug Administration for conditional marketing, the protection effectiveness meets the requirements of the World Health Organization and the relevant standards of the State Drug Administration, and will be provided free of charge to all Chinese people in the future. As I predicted 8 months ago.